EU Digital Agenda 101: From Supporting Research To Meeting Social Challenges 13/02/2013 by Intellectual Property Watch Leave a Comment The following is a reprint from the EU research and development network, Cordis, summarising recent activity on the EU Digital Agenda. The Digital Agenda for Europe and its 101 actions form a vital part of the overall Europe 2020 strategy for securing smart, sustainable and inclusive growth. The actions are organised in seven pillars, or ‘containers’: digital single market, interoperability and standards, trust and security, fast and ultra-fast internet access, research and innovation, digital literacy, skills and inclusion, and ICT-enabled benefits for EU society. In the previous part of this story we covered the digital single market, interoperability, security, and fast internet access. Next we look at ICT support for research…
USPTO Finalises Rules For ‘First-Inventor-To-File’ System Switch 13/02/2013 by Kelly Burke for Intellectual Property Watch 1 Comment The United States Patent and Trademark Office (USPTO) today published final rules of practice implementing the “first-inventor-to-file” provision of the Leahy-Smith America Invents Act (AIA). This comes just days after a change in patent fees.
Event Explains Partnerships In Natural Products Research Through Thai Experience With Novartis 13/02/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch Leave a Comment Alongside the World Intellectual Property Organization meeting on protection of genetic resources last week, the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) organised a side event on natural product research.
WIPO Side Event Addresses Recent Developments Related To The Nagoya Protocol 13/02/2013 by Tiphaine Nunzia Caulier for Intellectual Property Watch 1 Comment At the World Intellectual Property Organization meeting on protection of genetic resources last week, the secretariat of the UN Convention on Biological Diversity (CBD) organised a side event to introduce the key features and recent developments of the international protocol on access and benefit-sharing of such resources.
President Obama Calls For Dramatic Increase In R&D, Major Trade Deals 13/02/2013 by Intellectual Property Watch 1 Comment In the annual state of the union speech, newly re-elected US President Obama outlined numerous initiatives aimed at strengthening the United States inwardly, but he also kept his eye on international competitiveness. For instance, he called for a massive increase in research and development, as well as a focus on education and skills, manufacturing, science and innovation, and international trade agreements with Asia and Europe.
Texts Show Details Of EU Parliament Transparency Directive Vote 13/02/2013 by Intellectual Property Watch Leave a Comment The European Parliament last week overwhelmingly adopted a text on transparency that was said to improve conditions for generic medicines in the region. The voting documents are now available.
Report Finds Average US Patent Cost US$ 374,000 In 2012 12/02/2013 by Intellectual Property Watch 2 Comments A new quarterly report on patent sales by technology shows that in 2012 the median price paid for issued US patents was US$ 221,000, while the average price paid was US$ 374,000.
UK Appoints IP Attaché To ASEAN Countries 12/02/2013 by Intellectual Property Watch 1 Comment The United Kingdom Intellectual Property Office has appointed its fourth IP attaché, this time to represent UK businesses in the 10 countries that make up the Association of Southeast Asian Nations (ASEAN).
Intellectual Ventures Sues Internet Providers For DSL Patent Infringement 12/02/2013 by Intellectual Property Watch 1 Comment Intellectual Ventures, a patent holding company, has filed a patent infringement suit against DSL providers AT&T, CenturyLink and Windstream Communications.
Letter Shows US Pressure On Global Fund For Compulsory Licensing, Generics 12/02/2013 by William New, Intellectual Property Watch Leave a Comment A 2011 letter from the top Republican on the United States Senate Finance Committee condemned efforts by the Global Fund to train public health officials on the use of flexibilities to the patent system contained in international trade rules. The letter, which also attacked the purchase of generic medicines over brand-name drugs, came just months before the US helped remove the head of the Global Fund, ultimately replacing him with an American official.